Blog Articles

Early nerve and muscle dysfunction may be among the first warning signs of neurological diseases like Parkinson’s, according to exciting new research published by Neuroscience News and EMBO Molecular Medicine.

Multiple Sclerosis (MS) is a chronic autoimmune condition that affects the central nervous system and can lead to symptoms like numbness, weakness, vision changes, and mobility challenges.

Electromyography (EMG) is a powerful diagnostic tool used by neurologists to assess muscle and nerve function.

Emerging research from Stanford shows that restoring microglial function using cell therapy could offer new hope for Alzheimer's disease patients.

Scientists have discovered that GLP-1 receptor agonists may reduce inflammation in the brain, support better blood flow, and protect against the buildup of amyloid plaques—hallmarks of Alzheimer’s disease.

An area often overlooked is the intersection between women’s hormonal health and long-term cognitive function. New research is now bringing much-needed attention to this critical issue—especially for women who experience early menopause.

Early diagnosis of dementia is key to improving outcomes and maintaining quality of life—but traditional methods often miss subtle early signs.

New research reveals that chronic fatigue in cancer patients isn’t just physical—it's deeply tied to inflammation in the brain and nervous system.

Recent research reveals a powerful link between oral health, migraines, and fibromyalgia—conditions that affect millions across the U.S. For patients in Phoenix, AZ, where migraines and chronic pain are common neurological complaints.

New Alzheimer’s research has uncovered a promising treatment target—TIM-3, a brain immune cell receptor that may help reduce inflammation and slow cognitive decline.

Update: We have a new study indication - seizure disorder!

Recent studies show a strong connection between heart failure and cognitive decline, highlighting significant implications for brain health in patients with cardiovascular disease.

Recent groundbreaking studies have revealed a critical link between herpes simplex virus type 1 (HSV-1) infection and increased Alzheimer's risk.

Cost-effective, noninvasive screening methods for preclinical Alzheimer’s disease (AD) and other neurocognitive disorders remain an unmet need. The olfactory neural circuits develop AD pathological changes prior to symptoms.

At the Center for Neurology and Spine in Phoenix, Arizona, our expert neurologists continuously monitor breakthrough studies to provide the most advanced Alzheimer's and dementia treatments.

​We are thrilled to announce that Ashely Mitchell, a distinguished speaker from Arizona Neuroscience Research (ANR), will be presenting at the upcoming MAGI 2025 Clinical Research Conference.

Now Enrolling Participants!

At Center for Neurology and Spine (CNSofAZ.com), we are committed to staying at the forefront of neurological research and treatment. New studies continue to strengthen the link between Epstein-Barr Virus (EBV) and multiple sclerosis (MS).

Two recent studies—one from Neuroscience News and another published in Science—highlight how cutting-edge brain mapping techniques are helping neurologists gain unprecedented insights into the disease process of MS (Neuroscience News, Science).

A recent study reported by Neuroscience News has raised important questions about the long-term use of selective serotonin reuptake inhibitors (SSRIs) and their potential link to accelerated cognitive decline

A recent study published in Stroke by the American Heart Association (DOI: 10.1161/STROKEAHA.124.050359) offers important insights into stroke recovery and prevention—information that is particularly relevant for our community in Arizona.

Recent studies have highlighted that commonly used medications—such as antibiotics, vaccines, and anti-inflammation, may not only serve their primary purposes but also play a role in reducing the risk of dementia.

Are you or a loved one living with multiple sclerosis (MS) in Arizona? An exciting new clinical trial, the MoonStone Study, is now enrolling participants at Arizona Neuroscience Research (www.azneuroscienceresearch.com).

At the Center for Neurology and Spine, we stay on the cutting edge of research that links neurological conditions to other parts of the body.

A study published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association reveals that individuals who experience prolonged latency in entering REM sleep exhibit higher levels of amyloid-beta and tau proteins—hallmarks of Alzheimer's.

Drugs that are associated with a reduced risk of dementia.

What is the POWER1 Study? The POWER1 Study evaluates a new investigational medication, vormatrigine, for adults with focal onset seizures.

Dementia is a growing concern in the United States, with recent studies indicating that nearly 1 in 2 Americans over the age of 55 may develop the condition in their lifetime.

At the Center for Neurology and Spine, we are dedicated to providing cutting-edge insights into Alzheimer’s research and treatment.

merging research suggests a significant link between chronic human cytomegalovirus (HCMV) infections and Alzheimer's disease (AD), shedding light on potential new avenues for treatment and prevention.

Emerging research reveals intriguing connections between Herpes Simplex Virus 1 (HSV-1) and Alzheimer’s disease (AD). This groundbreaking evidence explores how viral activity interacts with hallmark Alzheimer’s pathologies.

At the Center for Neurology and Spine, we are deeply invested in exploring how various lifestyle factors, including diet, influence neurological health.

In the realm of neurology, the electroencephalogram (EEG) has long been a cornerstone diagnostic tool—allowing clinicians to measure electrical brain activity, detect seizure patterns, and guide treatments for conditions like epilepsy, sleep disorders, and

At CNS of Arizona, we’re committed to staying at the forefront of neurological care—especially when it comes to leveraging the latest imaging techniques to improve patient outcomes.

Carpal Tunnel Syndrome (CTS) is a common condition that affects millions of people, causing pain, numbness, and tingling in the hand and arm. If you're experiencing these symptoms, your doctor may recommend an Electromyography (EMG) test.

If you've been experiencing unexplained muscle weakness, numbness, or tingling sensations, your doctor might recommend an Electromyography (EMG) test. But what is an EMG, and how does it relate to conditions like Multiple Sclerosis (MS)?

For those residing in Arizona and covered by Aetna health insurance, the current discourse surrounding the contract negotiations between Aetna and Dignity Health holds significant implications for your healthcare choices going forward.

Struggles to get to the clinic? Trying to reduce your exposure to COVID-19, as well as other contagious illnesses, and still need to see your doctor? Telehealth is safe and easy — receive quality care from anywhere.

Blue Cross Blue Shield of Arizona (BCBSAZ) and Dignity Health have ended their deal. This means that services for Dignity Health in Maricopa and Pinal Counties will no longer be available. What's next?

The Center for Neurology and Spine in Phoenix, AZ, offers cutting-edge Botox treatments for neurological conditions, providing relief for chronic migraines, cervical dystonia, and spasticity. Specializing in comprehensive neurology services, in Phoenix AZ.

Neurology is a field that is always changing, so it is important to keep up with the latest developments. We are living in an exciting time of medical progress here in Phoenix. This blog post talks about some of the neurological changes this year so far...

As we continue to explore ways to manage Long COVID, recent research has revealed the potential of various supplements and prescription drugs. These include: Vitamin D and Zinc, N-acetylcysteine (NAC), Probiotics (SIM01), Guanfacine,

Finding a resource for clinical trials or other treatment options for multiple sclerosis can be challenging. The article below will show some resources that may be useful in navigating current and on-going clinical trials.

Cognitive testing is a critical diagnostic tool in neurology, facilitating the evaluation and diagnosis of a wide spectrum of cognitive disorders and conditions affecting brain function.

Electromyography (EMG) and nerve conduction studies (NCS)–also called a nerve conduction velocity test (NCV)–are invaluable diagnostic tools used in neurology to assess and diagnose a wide range of neuromuscular conditions.

Botox, originally known for its cosmetic applications, has emerged as an effective medical treatment for various neurological conditions, including chronic migraine, cervical dystonia, and spasticity.

Stroke, a sudden disruption of blood flow to the brain, is a critical medical emergency with potentially life-changing consequences.

Nerve and muscle disorders, particularly neuropathy, encompass a spectrum of conditions that impact the nervous system, often leading to various sensory and motor symptoms.

Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) are complex neurological disorders that impact the central nervous system. The good news is, there have been significant advancements in the treatment of both MS and NMO.

Movement disorders encompass a range of neurological conditions that can significantly affect a person’s ability to control their bodily movements.

Headaches are a common neurological complaint that can range from mild discomfort to debilitating pain. In the United States, millions of people each year seek treatment for headaches.

Epilepsy, a neurological disorder characterized by recurring seizures, can significantly disrupt everyday life. These seizures, stemming from abnormal brain activity, come in various forms and can vary in their impact on sensations and behavior.

Dementia is a complex neurological condition that affects memory, cognitive function, and daily living. It primarily impacts older adults but can also occur in younger individuals.